The Traderszone Network

21 December, 2021 by The TZ Newswire Staff Comments Off on CSX Co. (NASDAQ:CSX) Receives Consensus Recommendation of “Buy” from Analysts

CSX Co. (NASDAQ:CSX) Receives Consensus Recommendation of “Buy” from Analysts

CSX Co. (NASDAQ:CSX) has received an average rating of “Buy” from the twenty-two ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and fourteen have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $37.08.

read more

21 December, 2021 by The TZ Newswire Staff Comments Off on Rudderless early morning markets, and backwards looking UK GDP won’t inspire excitement

Rudderless early morning markets, and backwards looking UK GDP won’t inspire excitement

Good morning all, 

It’s all feeling rather rudderless out there today, Asian equity markets are closing will millpond levels of flatness, following yesterday’s impressive edition of BTFD stateside.

Newsquawk’s top takes:

:: An indecisive tone was seen across APAC markets overnight
:: US equity fu

21 December, 2021 by The TZ Newswire Staff Comments Off on Zacks Investment Research Lowers Universal Insurance (NYSE:UVE) to Hold

Zacks Investment Research Lowers Universal Insurance (NYSE:UVE) to Hold

Universal Insurance Holdings, Inc. logoUniversal Insurance Holdings, Inc. logoZacks Investment Research upgraded shares of Marqeta (NASDAQ:MQ) from a hold rating to a buy rating in a research note released on Saturday, Zacks.com reports. The firm currently has $18.00 target price on the stock.

read more

21 December, 2021 by The TZ Newswire Staff Comments Off on Marqeta (NASDAQ:MQ) Upgraded by Zacks Investment Research to Buy

Marqeta (NASDAQ:MQ) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Marqeta (NASDAQ:MQ) from a hold rating to a buy rating in a research note released on Saturday, Zacks.com reports. The firm currently has $18.00 target price on the stock.

read more

21 December, 2021 by The TZ Newswire Staff Comments Off on Novo Nordisk A/S (NYSE:NVO) Rating Lowered to Hold at Danske

Novo Nordisk A/S (NYSE:NVO) Rating Lowered to Hold at Danske

Novo Nordisk A/S (NYSE:NVO) was downgraded by research analysts at Danske from a “buy” rating to a “hold” rating in a report issued on Monday, The Fly reports.

read more